For 2022 full year guidance, the Company estimates revenues between $375 million and $385 million, Adjusted EBITDA between $201 million and $207 million and Adjusted non-GAAP earnings per diluted share of between $5.36 and $5.50, excluding share-based compensation, amortization of acquired intangibles and the impact of unanticipated items, in the case of adjusted non-GAAP net income, net of tax.
Innovid Corp. Announced A Reduction Of Its Global Full-Time Headcount By Approximately 10%
On January 23, 2023, Innovid Corp. (the “Company”) announced a reduction of its global full-time headcount by approximately 10%. This headcount reduction reflects the Company’s continued focus on
